Anhui Provincial Hospital

This study is testing whether the time of day a patient receives donor stem cells can reduce the risk of a dangerous immune reaction called acute graft-versus-host disease (GVHD). It involves about 200 people with blood cancers who are getting a stem cell transplant. Researchers …

This early-stage study is testing an experimental injection called MegaLT for people with dangerously low platelet counts that haven't improved after cancer treatments like radiation, chemotherapy, or transplants. The trial will check if the treatment is safe, how the body proces…